Deltex Medical's market cap is currently ―. The company's EPS TTM is p-0.001; its P/E ratio is -1.22; Deltex Medical is scheduled to report earnings on September 16, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Jun 22	Dec 21	Jun 21	Dec 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	£ 471.00K	£ 626.00K	£ 413.00K	£ 568.00K	£ 853.00K
Total Assets	£ 6.18M	£ 6.06M	£ 5.39M	£ 5.15M	£ 5.53M
Total Debt	£ 2.23M	£ 2.00M	£ 2.00M	£ 1.47M	£ 1.47M
Net Debt	£ 1.76M	£ 1.37M	£ 1.59M	£ 900.00K	£ 614.00K
Total Liabilities	£ 3.95M	£ 3.43M	£ 3.49M	£ 3.00M	£ 2.89M
Stockholders Equity	£ 2.35M	£ 2.75M	£ 2.03M	£ 2.27M	£ 2.77M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in GBP

Deltex Medical Earnings and Revenue History

Income Statement >

Deltex Medical Debt to Assets

Balance Sheet >

Deltex Medical Cash Flow

Cash Flow >

Deltex Medical Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing